Our results demonstrate that 1p-22q-NF2- meningiomas without expression of GSTM1 comprise the recurrent 1p-22q-NF2- meningiomas compared to those that express GSTM1, thereby addressing the heterogeneity in this existing molecular classification scheme. This evidence concerns the gene NF2 and meningioma.